Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

M1 Kliniken AG

M12
Current price
16.5 EUR +0.05 EUR (+0.30%)
Last closed 16.45 EUR
ISIN DE000A0STSQ8
Sector Healthcare
Industry Medical Distribution
Exchange XETRA Stock Exchange
Capitalization 318 015 819 EUR
Yield for 12 month +86.65 %
1Y
3Y
5Y
10Y
15Y
M12
21.11.2021 - 28.11.2021

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas comprising oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG. Address: GrUenauer Strasse 5, Berlin, Germany, 12557

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

25.72 EUR

P/E ratio

18.3333

Dividend Yield

3.12 %

Current Year

+318 744 059 EUR

Last Year

+287 495 639 EUR

Current Quarter

+169 037 339 EUR

Last Quarter

+166 785 395 EUR

Current Year

+26 850 098 EUR

Last Year

+21 891 415 EUR

Current Quarter

+22 878 417 EUR

Last Quarter

+14 732 955 EUR

Key Figures M12

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 25 149 785 EUR
Operating Margin TTM 8.63 %
PE Ratio 18.3333
Return On Assets TTM 6.72 %
PEG Ratio
Return On Equity TTM 12.8 %
Wall Street Target Price 25.72 EUR
Revenue TTM 335 841 494 EUR
Book Value 5.94 EUR
Revenue Per Share TTM
Dividend Share 0.5 EUR
Quarterly Revenue Growth YOY 11.2 %
Dividend Yield 3.12 %
Gross Profit TTM 31 474 328 EUR
Earnings per share 0.91 EUR
Diluted Eps TTM 0.91 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 211.8 %
Profit Margin 5.03 %

Dividend Analytics M12

Dividend growth over 5 years

Continuous growth

1 year

Payout Ratio 5 years average

54 %

Dividend History M12

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.5
Ex Dividend Date 18.07.2024
Forward Annual Dividend Yield 3.03 %
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation M12

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 18.3333
Forward PE
Enterprise Value Revenue 0.9079
Price Sales TTM 0.9469
Enterprise Value EBITDA 9.6331
Price Book MRQ 2.8856

Financials M12

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators M12

For 52 weeks

8.48 EUR 21.93 EUR
50 Day MA 17.01 EUR
Shares Short Prior Month
200 Day MA 15.88 EUR
Short Ratio
Shares Short
Short Percent